CD44 and breast carcinoma: The migration of CD44-blocked MDA-MB-231 cells to BMCM was only reduced to a level similar to untreated cells exposed to BMCM depleted of OPN, suggesting that CD44 specifically contributes to the effect of bone-derived OPN on breast cancer cell migration (P>0.05; Fig 3A).